Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. Radiation. University of Chicago Medical Center , Chicago, Illinois, United States

Survival: 18.3 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Gemzar
Country: United States
City/State/Province: Chicago, Illinois
Hospital: University of Chicago Medical Center
Journal: Link
Date: 10/2002

Patients: This Phase II study involved a total of 175 patients with stage III non-small cell lung cancer. Patients were divided into three groups. Group A contained 62 patients. Group B contained 58 patients. Group C contained 55 patients.

Treatment: Patients in Group A were administered two chemotherapy drugs cisplatin (platinol) and gemcitabine (gemzar), plus chest radiotherapy.

Toxicity: Grade 4 toxicities for patients in Group A consisted of hematologic, nausea and vomiting.

Results: Median survival for patients in Group A was 18.3 months.

Correspondence: Everett E. Vokes, MD

E-mail to a Friend Email Physician More Information